Shuttle Pharmaceuticals Holdings (SHPH) Non-Current Deferred Tax Liability (2022 - 2025)

Shuttle Pharmaceuticals Holdings' Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $5748.0 for Q4 2025.

• In Q4 2025, Non-Current Deferred Tax Liability fell 68.35% year-over-year to $5748.0; the TTM figure through Dec 2025 stood at $5748.0 (down 68.35% YoY), while the FY2025 annual figure was $5748.0, down 68.35% from the prior year.
• Non-Current Deferred Tax Liability was $5748.0 for Q4 2025 at Shuttle Pharmaceuticals Holdings, down from $18163.0 in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $106914.0 in Q4 2022 to a low of $5748.0 in Q4 2025.
• Historically, Non-Current Deferred Tax Liability has averaged $46014.5 across 4 years, with a median of $35698.0 in 2023.
• The sharpest annual moves came in 2023 and 2025: Non-Current Deferred Tax Liability sank 50.21% in 2023, then tumbled 68.35% in 2025.
• A 4-year view of Non-Current Deferred Tax Liability shows it stood at $106914.0 in 2022, then tumbled by 50.21% to $53233.0 in 2023, then sank by 65.88% to $18163.0 in 2024, then sank by 68.35% to $5748.0 in 2025.
• The last three Non-Current Deferred Tax Liability figures came in at $5748.0 (Q4 2025), $18163.0 (Q4 2024), and $53233.0 (Q4 2023), per Business Quant data.